<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Neoplasia Part 2: Specific Tumors & Spread | General Pathology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts - Inter for UI, Source Serif for reading -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link for Accessibility -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle (Fixed Position) -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Links will be populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="topic-08-neoplasia.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Neoplasia Pt.1</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">08-B</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">09</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 94%;"></div>
                            </div>
                            <span class="progress-label">Specific Tumors & Spread</span>
                        </div>
                        
                        <a href="topic-09-cytology-environmental.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item"><a href="topic-08-neoplasia.html">Neoplasia</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Specific Tumors & Spread</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">üî¨</span>
                        <span class="badge-text">Section 08-B</span>
                    </div>
                    <h1 class="document-title">Neoplasia: Spread & Specific Types</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üìÑ</span>
                            <span>TNM, Metastasis, Classification</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content Area -->
                <div class="content-wrapper">
                    
                    <!-- START: staging -->
                    <section id="staging" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">Tumor Staging (TNM)</h2>
                        </div>
                        
                        <div class="content-card">
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>TNM Staging of carcinoma:</th>
                                                <th>TNM Staging of sarcoma:</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>T: represents tumor state &amp; size, graded <br> as Tis (tumor in situ), T1, T2 T3 &amp; T4.</td>
                                                <td>TNM system (modified)</td>
                                            </tr>
                                            <tr>
                                                <td>N: represents the degree of spread to <br> lymph nodes and is graded as NO,N1,N2 &amp; <br> N3 (NO means absent)</td>
                                                <td>T: usually graded as T1 or T2 according to <br> size</td>
                                            </tr>
                                            <tr>
                                                <td>M: represents metastases due to blood <br> spread and is graded as MO (absent) or <br> M1 (present).</td>
                                                <td>N: usually graded as NO &amp; N1 <br> M: graded as MO &amp; M1</td>
                                            </tr>
                                            <tr>
                                                <td>Examples T1 NOMO is early cancer stage <br> (better prognosis), while T4 N3 M1 is an <br> advanced stage (worst prognosis).</td>
                                                <td></td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: staging -->

                    <!-- START: locally-malignant -->
                    <section id="locally-malignant" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">Characteristics of Locally Malignant Tumors</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>This is a group of intermediate malignant tumors characterized by</p>
                            <ol class="enhanced-list">
                                <li class="list-item">A slower rate of growth than frank malignant tumors</li>
                                <li class="list-item">Local invasion without distant spread</li>
                                <li class="list-item">Microscopic features of malignancy.</li>
                            </ol>
                            <p>They may changes into frank malignant tumors.</p>
                            
                            <p><strong>Examples of locally malignant tumors:</strong></p>
                            <ol class="enhanced-list">
                                <li class="list-item">Basal cell carcinoma.</li>
                                <li class="list-item">Giant cell tumour of bone (Osteoclastoma) (grade II).</li>
                                <li class="list-item">Adamantinoma.</li>
                                <li class="list-item">Craniopharyngioma.</li>
                                <li class="list-item">Bronchial adenoma.</li>
                                <li class="list-item">Carcinoid tumour.</li>
                                <li class="list-item">Astrocytoma (grade II).</li>
                            </ol>

                            <h3 id="remarks">REMARKS:</h3>
                            <p>Carcinomas arise from epithelium, while sarcomas arise from mesenchyme. The normal epithelium is characterized by cohesive (adherent) cells resting on basement membranes. The type (differentiation) of normal epithelial tissue is determined by cell type &amp; cell arrangement (e.g. glandular or stratified). The normal mesenchyme mostly consists of noncohesive spindle cells The type (differentiation) of mesenchyme is largely determined by cell products which may be extracellular as collagen (fibroblasts) &amp; osteoid (osteoblasts) or intracellular as actin &amp; myosin.</p>
                        </div>
                    </section>
                    <!-- END: locally-malignant -->

                    <!-- START: tumour-like -->
                    <section id="tumour-like" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">TUMOUR-LIKE lesions</h2>
                        </div>
                        
                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item">Hamartomas: Hemangioma - lymphangioma &amp; Pigmented nevi-Osteochondroma/ osteochondromatosis.</li>
                                <li class="list-item">Granuloma</li>
                                <li class="list-item">Choristoma: microscopically normal tissue in abnormal sites</li>
                                <li class="list-item">Fibromatosis &amp; desmoid</li>
                            </ul>

                            <h3 id="hamartoma">HAMARTOMA</h3>
                            <p>This is a tumor-like developmental malformation formed of noncapsulated mature tissues of the affected organ, arranged haphazardly. It usually stops growing after puberty. Some hamartomas are precancerous.</p>
                            
                            <p><strong>Examples of hamartomas:</strong></p>
                            <ol class="enhanced-list">
                                <li class="list-item">Lung hamartoma (a mixture of cartilage, smooth muscle and bronchial mucosal tissue).</li>
                                <li class="list-item">Kidney hamartoma</li>
                                <li class="list-item">Angiomas,</li>
                                <li class="list-item">Pigmented nevi.</li>
                                <li class="list-item">Exostosis &amp; neurofibromatosis are regarded as hamartomatous malformations.</li>
                            </ol>
                        </div>
                    </section>
                    <!-- END: tumour-like -->

                    <!-- START: spread -->
                    <section id="spread" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">04</div>
                            <h2 class="section-title">SPREAD OF MALIGNANT TUMORS</h2>
                        </div>
                        
                        <div class="content-card">
                            <p>Malignant tumors spread locally to surrounding tissues and distantly to remote sites (metastases).</p>
                            
                            <h3 id="mechanism-spread">Mechanism:</h3>
                            <p>Gene mutation: results in new tumour associated (TAA) antigens on surface of cell. This changes the surface molecule receptors with loosening of Intercellular junctions &amp; loss of contact inhibition: E Cadherin loss results in proliferation and invasion</p>
                            
                            <h4 id="invasion-ecm">1) Invasion of Extracellular Matrix (ECM): The following steps are included:</h4>
                            <ul class="enhanced-list">
                                <li class="list-item">Loss of cellular cohesion: Normal cells are glued together by molecules called cadherins. Tumor cells lose the normal cadherin expression, allowing them to detach (loosening up).</li>
                                <li class="list-item">Attachment of tumor cells (through receptors) to matrix components; mainly to laminin of basement membrane and fibronectin of the interstitial tissue . Attachment to ECM promotes the next steps.</li>
                                <li class="list-item">Degradation of the ECM by proteolytic enzymes secreted by the tumor cells or by stimulated host cells (fibroblasts &amp; macrophages). Several enzymes are released as type IV collagenase (causing lysis of basement membranes of epithelia and of vessels) and cathepsin D (causing degradation of interstitium). Degradation of ECM is very important for the tumor cells to create passage ways for their migration.</li>
                                <li class="list-item">Migration (mobility) of tumor cells (by pseudopodia). This is mediated by tumor-derived cytokines (mobility factors) such as "autocrine mobility factor". The process may be helped by acquiring negative charges on surface of tumor cells causing their repulsion and loss of contact inhibition.</li>
                            </ul>

                            <h4 id="vascular-dissemination">2) Vascular Dissemination and Homing of Tumor Cells:</h4>
                            <ul class="enhanced-list">
                                <li class="list-item">Tumor mobility allows cells to come in contact with lymphatics, capillaries, venules or arterioles.</li>
                                <li class="list-item">Tumor cell can penetrate lymphatics, capillaries &amp; venules, but rarely the thickwalled arterioles.</li>
                                <li class="list-item">Once the tumor cells cross the vascular basement membranes, they reach circulation as tumor emboli, where most of them get destroyed by immune mechanisms. The surviving tumor cells adhere to platelets &amp; get impacted in small vessels, where they adhere to the endothelium, cross the basement membrane (by mechanisms similar to those described above) &amp; settle in the new site (homing). In their new sites, tumor cells proliferate forming metastatic deposits (metastasis, secondary tumors).</li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="routes-of-spread">ROUTES OF SPREAD</h3>
                            <p><strong>LOCAL (DIRECT) SPREAD</strong> Tumor cells invade adjacent structures in direct continuity e.g. cancer: tongue can directly spread to the floor of mouth</p>

                            <h4 id="distant-spread">DISTANT SPREAD (METASTASIS):</h4>
                            <p><strong>A) LYMPHATIC SPREAD:</strong> Occurs more commonly with carcinomas than sarcomas</p>
                            <p><strong>i) Lymphatic embolism:</strong><br>
                            Malignant cells invade the wall of lymphatic vessels $\rightarrow$ tumor emboli $\rightarrow$ lymph node.</p>
                            <ul class="enhanced-list">
                                <li class="list-item">Spread from one node to another may occur by efferent lymphatics.</li>
                            </ul>
                            <p>Grossly: The affected nodes are enlarged &amp; firm. They may become fused &amp; fixed.<br>
                            Microscopically the metastatic deposit resembles the primary tumor from which it is derived.</p>
                            <ul class="enhanced-list">
                                <li class="list-item">Progressive spread by the lymphatic route may ultimately lead to tumor emboli within the main lymphatic ducts (thoracic duct), from which tumor emboli reach the venous circulation causing hematogenous spread</li>
                            </ul>
                            
                            <p><strong>ii) Lymphatic permeation</strong> $\rightarrow$ lymphatic obstruction $\rightarrow$ lymphatic oedema.<br>
                            Example: Breast carcinoma $\rightarrow$ permeation of axillary lymphatics $\rightarrow$ oedema of the whole arm</p>

                            <p><strong>B) HEMATOGENOUS (BLOOD) SPREAD: COURSE:</strong></p>
                            <ul class="enhanced-list">
                                <li class="list-item">Emboli derived from primary tumors of organs drained by systemic veins (vena cava) e.g. breast, and kidney $\rightarrow$ pulmonary arteries $\rightarrow$ lung metastases.</li>
                                <li class="list-item">Emboli derived from tumors of lungs (whether primary or metastatic) are carried through pulmonary veins to left side of heart and systemic arterial and systemic arterial circulation $\rightarrow$ metastases in different organs as liver, bones, brain ... etc.</li>
                                <li class="list-item">Emboli derived from tumors of organs drained by the portal vein (tumors of gastrointestinal tract) $\rightarrow$ liver metastases. Further spread from liver gives rise to emboli that reach the hepatic veins $\rightarrow$ inferior vena cava to lungs ... etc.</li>
                                <li class="list-item">Emboli reaching the vertebral system of veins from tumours of pelvic, abdominal or thoracic organs lead to metastasis in brain, spinal cord &amp; vertebrae without causing lung metastasis since vertebral veins have wide anastmotic channels connecting them with lumbosacral, abdominal &amp; thoracic veins.</li>
                            </ul>

                            <h4 id="pathology-metastases">PATHOLOGY OF ORGAN METASTASES:</h4>
                            <p>The most common sites of metastases include the liver, lungs, bones &amp; brain.<br>
                            Metastases are rare in muscles ,spleen, pancreas &amp; intestine.<br>
                            Gross picture Metastases appear as scattered round nodules of variable sizes:<br>
                            Microscopic picture: Metastases resemble the primary tumor from which they are derived.</p>
                            <p>Bone metastases: May be osteolytic but in case of cancer prostate it may be osteosclerotic (new bone formation is stimulated around the metastatic deposit, since malignant cells of prostatic origin secrete phosphatase).</p>

                            <p><strong>C) SPREAD THROUGH BODY CAVITIES (TRANSCOELOMIC SPREAD):</strong><br>
                            When the serosal covering of an organ is infiltrated by malignant cells of a tumor within this organ, some of these cells may detach and become implanted in other sites. This may be associated with hemorrhagic effusion. Transcoelomic spread includes:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">Transperitoneal spread from carcinoma of stomach, colon, pancreas...etc cause metastatic peritoneal/ omental nodules accompanied by hemorrhagic ascites. In females, carcinoma of stomach (or colon) may be associated with bilateral ovarian metastases, termed "Krukenberg tumors" which were considered to represent transcoelomic spread. They are now believed to be due to retrograde lymphatic or blood spread, since Krukenberg tumors can also occur in case of cancers of breast, urinary bladder &amp; biliary tract.</li>
                                <li class="list-item">Transpleural and transpericardial spread from lung or breast cancer resulting in metastases on the diaphragm accompanied by hemorrhagic pleural or pericardial effusion.</li>
                                <li class="list-item">Malignant tumors of brain may give rise to tumor cells within the CSF leading to metastases within the lining of the ventricles, base of skull and spinal cord.</li>
                            </ol>

                            <p><strong>D) OTHER METHODS OF SPREAD:</strong></p>
                            <ol class="enhanced-list">
                                <li class="list-item">Transluminal spread: malignant cells detached from transitional carcinoma of the renal pelvis may become implanted in the mucosa of urinary bladder forming secondary deposits.</li>
                                <li class="list-item">Surgical implantation/ Innocculation:
                                    <ul class="enhanced-list">
                                        <li>a) Instruments contaminated with malignant cells during surgical management of a tumor may transfer tumor cells into the surgical wound causing secondary tumor deposits.</li>
                                        <li>b) Implantation from carcinoma of lower lip may lead to a secondary tumor in the upper lip</li>
                                    </ul>
                                </li>
                            </ol>
                        </div>

                        <div class="content-card">
                            <h3 id="causes-death-malignancy">Causes of death In Malignant tumours</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">Malnutrition: obstruction-anorexia-Ioss of absorption- Macrophage TNF alpha &amp; toxic tumour metabolites(toxemia).Tumour interferes with food intake absorption &amp; digestion</li>
                                <li class="list-item">Anemia due to:
                                    <ul class="enhanced-list">
                                        <li>&gt; Hemorrhages: invasion of blood vessels</li>
                                        <li>&gt; Bone Marrow metastasis: causes destruction of marrow</li>
                                        <li>&gt; Hemolysis: is an immune reaction</li>
                                        <li>&gt; Folic acid def: due to malnutrition</li>
                                    </ul>
                                </li>
                                <li class="list-item">Cachexia: severe form of protein calorie malnutrition causing wasting of body (loss of wt-anemiaweakness): Malnutrition-TNF alpha&amp; toxic metabolites-anorexia &amp; decrease Fat metabolism- low resistance to infection (malnutrition &amp; low immunity)</li>
                            </ul>
                            <p>CP: Wasting - Pallor- malaise &amp; fever +/- 2ry infections</p>
                            <ul class="enhanced-list">
                                <li class="list-item">Local complications due to organ destruction or affection
                                    <ul class="enhanced-list">
                                        <li>A) Renal failure: obstruction &amp; local tissue destruction if metastatic &amp; bilateral</li>
                                        <li>B) Hepatic failure &amp; obstructive jaundice</li>
                                        <li>C) Increase intracranial tension &amp; pressure on vital centers</li>
                                    </ul>
                                </li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: spread -->

                    <!-- START: specific-epithelial -->
                    <section id="specific-epithelial" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">05</div>
                            <h2 class="section-title">Epithelial Tumours</h2>
                        </div>

                        <div class="content-card">
                            <h3 id="benign-epithelial">A) BENIGN TUMOURS OF EPITHELIAL ORIGIN</h3>
                            
                            <h4 id="papilloma">1. Papilloma: A benign exophytic tumor of surface epithelium.</h4>
                            <p>A benign noncapsulated tumor of surface epithelium. Papillomas are classically exophtic (projecting) papillary tumors, composed of proliferated epithelial cells resting on intact basement membranes, supported from below by connective tissue core; containing blood vessels. Papillomas are rarely inverted endophytic lesions (that push the basement membrane and grow inwards, pushing the subepithelial tissues; of course without invasion) e.g. inverted papillomas of urinary bladder and nose. Classical papilloma may be sessile or pedunculated, single or multiple, they are classifies (according to type of epithelium) into:</p>

                            <p><strong>A) SQUAMOUS CELL PAPILLOMA:</strong></p>
                            <p>Definition &amp; origin: A benign tumor of stratified squamous epithelium<br>
                            Sites: Skin, lip, tongue, oral mucosa, pharynx, larynx, oesophagus, cervix, vagina and anal canal.</p>
                            <p>Gross Picture: Small sessile or pedunculated projection.<br>
                            Microscopic Picture: Connective tissue cores covered by thick proliferated stratified squamous epithelium</p>

                            <p><strong>B) OTHER TYPES OF PAPLLOMA:</strong></p>
                            <p><strong>Transitional cell papilloma (villous papilloma):</strong><br>
                            Definition &amp; origin: A benign tumor arising from urothelium (transitional mucosa of urinary tract). It is strongly pre-malignant.<br>
                            Sites: urinary bladder, ureter or renal pelvis.<br>
                            Gross Picture: The tumor appears as a noncapsulated velvety friable mass of delicate papillary processes.<br>
                            Microscopic Picture: Delicate vascularized connective tissue cores covered by usually not more than six layers of regular transitional cells.</p>
                            <p><strong>Complications:</strong></p>
                            <ol class="enhanced-list">
                                <li class="list-item">Bleeding (hematuria).</li>
                                <li class="list-item">Malignant change into transitional cell carcinoma</li>
                                <li class="list-item">Urethral or ureteric obstruction</li>
                            </ol>

                            <p><strong>Columnar cell papilloma:</strong> A benign tumor arising from columnar cells e.g. duct papilloma of the breast &amp; mucous cell papilloma (Adenomatous Polyp): of gastrointestinal mucosa.</p>
                            
                            <p><strong>1- DUCT PAPILLOMA:</strong><br>
                            Definition &amp; origin: A benign tumor arising from the epithelium of major ducts;<br>
                            Sites: Major ducts, as those of breast (most common) or pancreas.<br>
                            Gross Picture: It usually appears as a small complex papillary projection inside the duct lumen.<br>
                            Microscopic Picture: Delicate vascular cores covered by regular ductal epithelial cells.<br>
                            Complications: 1) Bleeding per nipple 2) Malignant transformation into duct carcinoma.</p>

                            <p><strong>2. MUCOUS CELL PAPILLOMA (Adenomatous Polyp, adenopapilloma, mucosal adenoma):</strong><br>
                            Definition, origin and Sites: A benign tumor of mucosa. Sites: Gastrointestinal tract is the commonest site.<br>
                            Gross Picture: It appears as a sessile, pedunculated or complex papillary projection.<br>
                            Microscopic Picture: Proliferated mucosal glands lined by columnar epithelium, supported by fibrovascular stroma.<br>
                            Complications:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">Gastrointestinal bleeding is common.</li>
                                <li class="list-item">Malignant transformation into adenocarcinoma.</li>
                                <li class="list-item">Obstruction (e.g. pyloric obstruction)</li>
                            </ol>

                            <h4 id="adenoma">2- ADENOMA</h4>
                            <p>Definition, origin: A benign tumor arising from glandular epithelium</p>
                            <p>Sites:<br>
                            1- Exocrine or endocrine glands (breast, ovary, salivary glands ,pancreas ,thyroid, etc)<br>
                            2- Mucosal glands of GIT, endometrium ... etc (adenomatous polyp... see above)</p>
                            <p>Gross Picture: A capsulated globular or ovoid mass.<br>
                            Microscopic Picture: Several Patterns:<br>
                            1- Simple adenoma (tubular adenoma): proliferated glands separated by delicate fibrovascular stroma.<br>
                            Remark: Mucous cell papilloma, is grossly a papilloma (arising from surface epithelium), but microscopically is an adenoma (composed of proliferated mucosal glands), Therefore it is called adenopapilloma or adenomatous polyp<br>
                            2- Fibroadenoma : glandular as well as stromal proliferations. Breast is the main site.<br>
                            3- Cystadenoma: Adenoma with retained secretions $\rightarrow$ cystic dilatation. Example: ovarian cystadenoma.<br>
                            4- Papillary Cystadenoma: A cystadenoma with profound intracystic epithelial proliferation $\rightarrow$ papillae. Example: papillary cystadenoma of the ovary.<br>
                            5- Special types of adenomas arising in salivary glands (salivary gland adenomas) e.g.<br>
                            a. Pleomorphic adenoma: It is an adenoma with stroma rich In mucin and pseudocartilage foci<br>
                            b. Warthin's tumor (papillary cystadenoma lymphomatosum): It is a special type of papillary cystadenoma in which the epithelial cells appear oncocytic (large eosinophilic cells) and the stroma is rich in Iymhocytes</p>
                            <p>Complications:<br>
                            I) Adenoma of endocrine glands may be hormone secreting e.g. thyroid adenoma<br>
                            II) May change to malignant</p>
                        </div>

                        <div class="content-card">
                            <h3 id="malignant-epithelial">MALIGNANT EPITHELIAL TUMORS (CARCINOMA) (plate 10)</h3>
                            <p>I) Carcinomas of Surface Epithelium:<br>
                            (1)Squamous cell carcinoma.<br>
                            (2) Basal cell carcinoma.<br>
                            (3) Transitional cell carcinoma.</p>
                            <p>II) Glandular Carcinoma:<br>
                            (1)Adenocarcinoma.<br>
                            (2) Mucoid carcinoma.<br>
                            (3) Carcinoma simplex</p>

                            <h4 id="tcc">1. TRANSITIONAL CELL CARCINOMA (TCC)</h4>
                            <p>Definition &amp; Origin: A malignant tumor of transitional epithelium. It arises de novo or on top of villous papilloma.<br>
                            Sites: Urinary bladder, ureter and renal pelvis.</p>
                            <p>Gross Picture:<br>
                            1- Papillary Type:_A villous papilliferous growth with broad infiltrating base.<br>
                            2- Non-papillary Types:<br>
                            a) Fungating polypoid mass.<br>
                            b) Malignant ulcer.<br>
                            c) Infiltrative pattern.</p>
                            <p>Microscopic Picture<br>
                            1- Papillary TCC:Jhe malignant transitional cells overlie vascular connective tissue cores, usually more than 6 cell layers. Papillary TCC tends io invade less deeply than non-papillary TCC and hence has a better prognosis.<br>
                            2- Nonpapiliarv TCC:Jhe malignant transitional cells form solid groups.</p>
                            <p>Spread:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">Local</li>
                                <li class="list-item">Distant : mainly by lymphatics &amp; late by blood.</li>
                                <li class="list-item">Transluminal implantation may occur</li>
                            </ol>

                            <h4 id="squamous-cell-carcinoma">2) SQUAMOUS CELL CARCINOMA (Epidermoid Carcinoma)</h4>
                            <p>Definition &amp; Origin: A malignant tumor of stratified squamous epithelium.<br>
                            Sites:<br>
                            a. Skin<br>
                            b. Squamous mucous membranes as lip, tongue, mouth, pharynx, larynx, oesophagus, cervix, vagina &amp; anal canal<br>
                            c. Other mucous membranes on top of squamous metaplasia e.g. squamous cell carcinoma of urinary bladder on top of squamous metaplasia due to bilharziasis.</p>
                            <p>Predisposing factors:<br>
                            a) prolonged exposure to sun. b) squamous metaplasia &amp; leukoplakia.</p>
                            <p>Gross Picture: Several patterns:<br>
                            a) Fungating polypoid pattern.<br>
                            b) Ulcerative pattern:<br>
                            Irregular -Raised everted edges. - Rough necrotic floor.- Indurated base.-infiltrative pattern.</p>
                            <p>Microscopic Picture:<br>
                            The dermis or submucosa is infiltrated by malignant epithelial cells which in well differentiated neoplasms form "cell nests". These cell nests consist of malignant cells that replicate the organization of the normal epidermis i.e. the periphery of these nests shows basal cell differentiation, followed by prickle cells then granular cells with the center of the nests showing keratin. In less differentiated neoplasms fewer cell nests are formed &amp; in anaplastic carcinoma, no cell nests may be detected .<br>
                            Broder's grading of squamous cell carcinoma:<br>
                            Grade I: 75-100% of the tumor consists of cell nests.<br>
                            Grade II: 50-75% cell nests.<br>
                            Grade III: 25-50% cell nests.<br>
                            Grade IV: 0-25% cell nests.</p>
                            <p>Spread: Local, lymphatic and by blood.</p>

                            <h4 id="basal-cell-carcinoma">3) BASAL CELL CARCINOMA (Rodent Ulcer)</h4>
                            <p>Definition &amp; Origin: A locally malignant tumor arising from basal layer of skin.<br>
                            Sites:<br>
                            a. Skin exposed to sun, commonly that of face, particularly above an imaginary line drawn from the angle of the mouth to the lobule of ear, particularly at the inner and outer angles of eyes, side of nose and angie of mouth.<br>
                            b. Skin of extensor surface of arms and legs is less commonly affected</p>
                            <p>Predisposing factors: Prolonged exposure to sun.</p>
                            <p>Gross Picture Starts as a red papule: $\rightarrow$ ulcer which has the following features:<br>
                            Irregular-Raised, rolled in, beaded edges. Rough floor. - Firm base.</p>
                            <p>Microscopic Picture:<br>
                            The dermis is infiltrated by masses of malignant epithelial cells, the peripheral cells are columnar basal cells with palisade (parallel) arrangement, while the central cells are polyhedral. There are several variants of basal cell carcinoma e.g. the pigmented, type, where tumor masses contain excessive melanin pigment.</p>
                            <p>Spread: only local. However basal cell carcinoma may change malignant (basosquamous or squamous cell carcinoma) leading to distant spread.</p>

                            <h4 id="glandular-carcinomas">2) CARCINOMAS OF GLANDULAR ORIGIN</h4>
                            <p>DEFINITION &amp; ORIGIN &amp; SITES:<br>
                            These are malignant tumors arising from glandular epithelium:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">Of the mucosal surfaces (as gastrointestinal mucosa, endometrium or endocervix)</li>
                                <li class="list-item">Glandular organs (endocrine or exocrine glands as prostate, ovary, mammary gland, salivary glands... etc)</li>
                            </ol>
                            <p>GROSS PICTURE:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">In mucous surfaces the tumor pattern may be:
                                    <ul>
                                        <li>a) Fungating polypoid pattern.</li>
                                        <li>b) Malignant ulcer type.</li>
                                        <li>c) Infiltrative pattern (annular and diffuse subtypes).</li>
                                    </ul>
                                </li>
                                <li class="list-item">In endocrine and exocrine glands, the tumor forms an irregular infiltrative growth.</li>
                            </ol>
                            <p>SPREAD:<br>
                            1. Local<br>
                            2. Distant spread by : a) Lymphatics b) blood (late) c) transcoelomic</p>
                            
                            <p>MICROSCOPIC TYPES:</p>
                            
                            <p><strong>1) Adenocarcinoma:</strong><br>
                            Definition &amp; Origin: A malignant tumor of glandular epithelium.<br>
                            Sites:<br>
                            1- Endocrine and exocrine glands as pancreas, prostate, salivary glands, breast, ovaries.<br>
                            2- Mucous surfaces as GIT, gall bladder ,endometrium, cervix, bronchi.</p>
                            <p>Microscopic Picture:<br>
                            1- In well differentiated adenocarcinoma, the malignant cells show acinar arrangement. These malignant acini differ from the normal acini in several respects:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">They are irregular with no definite basement membranes.</li>
                                <li class="list-item">Their lumens are irregular</li>
                                <li class="list-item">The cells show malignant features (describe)</li>
                                <li class="list-item">They exist in abnormal sites (as submucosa, musculosa or serosa) due to infiltration.</li>
                                <li class="list-item">They may be cystically dilated (cystadenocarcinoma) if the malignant cell secretions are retained. Some malignant cells may show papillary proliferations (papillary adenocarcinoma or papillary cystadenocarcinoma).</li>
                            </ul>
                            <p>2- Less differentiated adenocarcinomas show less degrees of acinar differentiation.</p>

                            <p><strong>2) Mucin secreting carcinomas:</strong><br>
                            Two types:<br>
                            a- Mucinous adenocarcinoma (mucoid or colloid Carcinoma): This is an adenocarcinoma with abundant extracellular mucin secretion<br>
                            b- Signet Ring Cell Carcinoma The malignant cells show intracytoplasmic mucin that pushes the nuclei eccentrically. No acinar differentiation.</p>
                            
                            <p><strong>3) Carcinoma simplex (undifferentiated carcinoma, spheroidal cell carcinoma:</strong> These are malignant tumors of glandular origin, that neither exhibit acinar differentiation nor secrete mucin. Malignant cells form solid groups</p>
                            <p>Sites:<br>
                            1- Most common in breast<br>
                            2- Less common in other glandular sites mainly GIT.</p>
                            <p>Gross &amp; Microscopic Features<br>
                            1- Scirrhous Carcinoma: Grossly the tumor is firm, gritty &amp; ill-defined. Microscopically malignant cells are rounded and form small-sized solid groups surrounded by dense stroma.<br>
                            2- Medullary CarcinomaJencephaloid carcinoma): Grossly the tumor is more expansile and better defined than scirrhous carcinoma and appears relatively soft .Microscopically, malignant cells are rounded and form large-sized solid groups usually with more marked necrosis and little fibrous stroma.<br>
                            Spread: As adenocarcinoma, describe (1- local spread 2-Distant spread).</p>

                            <h4 id="other-carcinomas">4) OTHER TYPES OF CARCINOMA</h4>
                            <ul class="enhanced-list">
                                <li class="list-item">Urothelial carcinoma (transitional cell carcinoma): A malignant tumor of transitional epithelium occurring in the urinary tract; most commonly the urinary bladder. It is very common in Egypt due to bilharziasis</li>
                                <li class="list-item">Hepatocellular carcinoma: A malignant tumor of liver arising from hepatocytes. It is common in Egypt due to chronic hepatitis</li>
                                <li class="list-item">Choriocarcinoma: A rare malignant tumor of placenta</li>
                                <li class="list-item">Salivary gland carcinomas as adenoid cystic carcinoma, mucoepidermoid carcinoma &amp; acinic cell carcinoma</li>
                                <li class="list-item">Renal cell carcinoma</li>
                                <li class="list-item">Other types</li>
                            </ul>
                        </div>
                        
                        <div class="topics-grid">
                             <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-35cb94f1.jpeg" alt="Squamous papilloma" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Squamous papilloma</figcaption>
                            </figure>
                             <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-92e94205.jpeg" alt="Squamous cell carcinoma" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Squamous cell carcinoma</figcaption>
                            </figure>
                             <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-2beb483d.jpeg" alt="Adenoma" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Adenoma</figcaption>
                            </figure>
                             <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-a35a0e33.jpeg" alt="Basal cell carcinoma" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Basal cell carcinoma</figcaption>
                            </figure>
                             <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-464abbc1.jpeg" alt="Adenocarcinoma" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Adenocarcinoma</figcaption>
                            </figure>
                        </div>
                    </section>
                    <!-- END: specific-epithelial -->

                    <!-- START: specific-mesenchymal -->
                    <section id="specific-mesenchymal" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">06</div>
                            <h2 class="section-title">Mesenchymal Tumours</h2>
                        </div>

                        <div class="content-card">
                            <h3 id="benign-mesenchymal">BENIGN MESENCHYMAL TUMORS</h3>
                            
                            <h4 id="lipoma">1) LIPOMA (plate 9)</h4>
                            <p>Definition &amp; origin: A benign tumor of adipose tissue. It is the most common soft tissue tumor.<br>
                            Sites: 1- Anywhere in the body, but most commonly subcutaneous tissue, particularly at the region of shoulders, neck, back and buttocks. 2- Intermuscular septa. 3- Mediastinum, mesentery, omentum, retroperitoneal. 4- Wall of stomach and intestine, and organs as kidney.<br>
                            Gross Picture: A capsulated globular or ovoid, commonly lobulated yellowish soft greasy mass.<br>
                            Microscopic Picture:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">The tumor consists of lobules composed of mature fat cells (adipocytes) which are large vacuolated cells with flattened eccentric nuclei. The lobules are separated by fibrovascular septa.</li>
                                <li class="list-item">Rarely lipoma consists of immature or embryonic fat cells which are smaller than mature fat cells showing central nuclei and cytoplasmic vacuoles. This type of lipoma is called hibernoma</li>
                            </ul>
                            <p>Secondary changes &amp; malignant transformation: Malignant change into liposarcoma is extremely rare.</p>

                            <h4 id="fibroma">2) FIBROMA</h4>
                            <p>Definition &amp; origin: An uncommon benign tumor of fibrous tissue<br>
                            Sites: Dermis - Periosteum of bone - Organs as ovary<br>
                            Gross Picture: A grayish white firm globular mass.<br>
                            Microscopic Picture: The tumor consists of variable proportions of fibroblasts, collagen and blood vessels. Fibroblasts may be numerous "cellular fibroma". Fibroblasts appear as spindle shaped cells with elongated nuclei showing tapering ends. Hyaline or myxoid changes may occur.<br>
                            Secondary changes &amp; malignant transformation: Hyalinosis, myxomatous change &amp; calcification may occur. Malignant change into fibrosarcoma is very rare.</p>

                            <p><strong>FIBROMATOSIS:</strong><br>
                            Fibromatosis is a tumor-like non neoplastic aggressive proliferation of fibrous tissue extending to neighboring structures as muscle (benign infiltration), resulting in a noncapsulated irregular mass, that commonly recurs after surgical excision. The proliferating fibroblasts show no atypia and there is no distant spread of the lesion.. Aetiology is not clear.</p>

                            <p><strong>DESMOID TUMOR (AGGRESSIVE FIBROMATOSIS):</strong><br>
                            Desmoid tumor belongs to a group of lesions called fibromatosis of unclear pathogenesis Fibromatosis is characterized by non neoplastic aggressive reactive proliferation of fibrous tissue extending to neighboring structures (benign infiltration) resulting in a noncapsulated irregular tumor- like mass, that commonly recurs after surgical excision.<br>
                            The proliferating fibroblasts show no features of malignancy &amp; the lesion does not metastasize.<br>
                            The most common form of fibromatosis is abdominal desmoid which arises from the musculo-aponeurotic structures of the anterior abdominal wall in woman during or after pregnancy. There are many other types of fibromatosis as extra-abdominal desmoid, penile fibromatosis, palmar and plantar fibromatosis.</p>

                            <h4 id="chondroma">3) CHONDROMA (plate 9)</h4>
                            <p>Definition &amp; Origin: A benign tumor of cartilage<br>
                            Sites: 1- Within the interior of bone (enchondroma); most commonly short bones of hands &amp; feet test, less commonly at ends of long bones or in flat bones as pelvis; ribs, sternum &amp; scapula Enchondroma is usually solitary, but rarely multiple (enchondromatosis, Oilier's disease 2- 0 n the surface of bone (subperiosteal or juxtacortical chondroma). 3- Extraskeletal soft tissue chondroma and bronchial chondroma are rare.<br>
                            Gross Picture: A globular well demarcated mass, commonly nodular or lobulated. A thin outer capsule may be seen. The tumor is bluish gray and translucent.<br>
                            Microscopic Picture: Nodules of cartilage composed of hyaline matrix and cartilage cells residing inside their lacunae. Cartilage cells (chondrocytes) are rounded with vacuolated cytoplasm.<br>
                            Secondary changes &amp; malignant transformation: Myxoid change, calcification &amp; ossification are common .Malignant change into chondrosarcoma is rare in solitary chondroma &amp; more common in case of enchondromatosis.residing inside their lacunae. Cartilage cells (chondrocytes) are rounded with vacuolated cytoplasm.</p>

                            <h4 id="osteochondroma">4) OSTEOCHONDROMA (Exostosis, cancellous osteoma orechondroma)</h4>
                            <p>Definition, Origin and Sites: Osteochondroma is a developmental tumor-like abnormality (hamartoma) rather than a true neoplasm. It arises from aberrant lateral growth of the epiphyseal cartilage. They occur in long bones &amp; stop growing after puberty.<br>
                            Gross Picture: The lesion may be single or multiple (multiple exostosis, osteochondromatosis).<br>
                            The multiple type is a hereditary autosomal dominant disease. The lesion appears as a mushroomshaped lateral projection composed of a bony stalk and head covered by a cartilaginous cap.<br>
                            Microscopic Picture: Cancelious bone covered by cartilage.<br>
                            Complications: Malignant change into chondrosarcoma is more common in case of multiple exostosis.</p>

                            <h4 id="osteoma">5) OSTEOMA</h4>
                            <p><strong>OSTEOID OSTEOMA:</strong><br>
                            Definition &amp; Origin: Benign bone tumor composed of osteoid tissue<br>
                            Sites: Any bone, the commonest are femur and tibia.<br>
                            Gross Picture: The tumor is solitary, less than 2 cm in diameter (commonly less than 1 cm ). Its substance appears pink, gritty and friable. Osteoid osteomas arising below the periosteum are famous of exciting a tremendous amount of reactive bone that encircles the tumor so that in X ray films the tumor appears as a radiolucent small lesion (nidus), with dense sclerotic margins.<br>
                            Microscopic Picture: Trabeculae of poorly mineralized osteoid bone rimmed by proliferating osteoblasts. The intervening stroma is loose and richly vascularized.<br>
                            Complications: Osteoid osteoma causes a characteristic nocturnal pain which is dramatically improved by aspirin. Pain is caused by excess production of prostaglandin E2.</p>

                            <p><strong>COMPACT OSTEOMA: (Ivory Osteoma):</strong><br>
                            Definition, Origin &amp; Sites: Benign tumor arising in membranous bones of the skull.<br>
                            Gross Picture: A hemispherical, noncapsulated hard ivory-like mass.<br>
                            Microscopic Picture: concentrically arranged bone lamellae.<br>
                            Complications: Disfigurement and pressure symptoms e.g. proptosis.<br>
                            N.B.: OSTEOCHONDROMA is sometimes regarded as a type of osteoma called cancellous osteoma (describe)</p>
                            <p>Remark: Osteoblastoma is a similar lesion to osteoid osteoma with the following differences</p>
                            <ul class="enhanced-list">
                                <li class="list-item">Larger</li>
                                <li class="list-item">Painless</li>
                                <li class="list-item">More common in the spine.</li>
                            </ul>

                            <h4 id="myxoma">6) MYXOMA</h4>
                            <p>Definition &amp; Origin: A rare benign tumor arising from remnants of primitive mesenchyme.<br>
                            Sites: I he commonest sites are the heart (particularly atrial) and jaw (in relation to teeth).<br>
                            Gross Picture: A soft gelatinous mass.<br>
                            Microscopy: Stellate shaped myxoma cells embedded in mucoid matrix.<br>
                            Complications &amp; secondary changes: Cardiac myxoma may be serious. It may be pedunculated and blocks the atrlo-ventricular valves. Malignant change may occur.<br>
                            Secondary hemorrhage and cyst formation may occur.</p>

                            <h4 id="myomas">7) BENIGN TUMORS OF MUSCLES (MYOMAS)</h4>
                            <p><strong>A) LEIOMYOMA</strong><br>
                            Definition &amp; Origin: A benign tumor of smooth muscle.<br>
                            Sites: It is a common tumor. Sites include:<br>
                            1- Uterus is the most common site. Leiomyoma is the commonest tumor in females. It occurs during the reproductive period of life and is oestrogendependent.<br>
                            2- Wall of oesophagus, stomach, intestine, urinary bladder and skin.<br>
                            Gross Picture (of uterine leiomyoma):</p>
                            <ul class="enhanced-list">
                                <li class="list-item">Single or multiple.</li>
                                <li class="list-item">Occurs within the myometrium (intramural, interstitial), but may also occur beneath the serosa (subserous) or immediately beneath the endometrium (submucous).</li>
                                <li class="list-item">Sharply circumscribed, round and firm.</li>
                                <li class="list-item">Uncapsulated but may acquire false capsule of compressed surrounding muscles.</li>
                                <li class="list-item">The cut section is grayish or grayish brown and usually shows a whorly appearance.</li>
                            </ul>
                            <p>Microscopic Picture:<br>
                            1- Interlacing bundles of smooth muscle cells, which are spindle shaped cells that differ from fibroblasts in having more abundant eosinophilic cytoplasm and rod-shaped nuclei having blunt (non-tapering) ends.<br>
                            2- Fibrous stroma containing blood vessels. This fibrous stroma may be abundant (particularly after the menopause) and the tumor may then be called fibromyoma or fibroid.<br>
                            3- Secondary changes as hyaline, myxoid and cystic changes, ischemic necrosis and calcification are common.<br>
                            Complications: 1- Malignant change into leiomyosarcoma is extremely rare. 2-Uterine myoma may lead to uterine bleeding and infertility</p>

                            <p><strong>B) RHABDOMYOMA</strong><br>
                            Definition &amp; Origin: An extremely rare benign tumor of striated muscles.</p>

                            <h4 id="angioma">8) BENIGN TUMORS OF VESSELS (ANGIOMA)</h4>
                            <p>Definition:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">Benign lesions ( hamartomas) composed of vascular spaces filled with Blood (hemangioma) or Lymph (lymphangioma).</li>
                                <li class="list-item">They are usually detected in early life (congenital tumor-like malformations (hamartomas) rather than true neoplasms.</li>
                                <li class="list-item">They do not change malignant.</li>
                            </ul>

                            <p><strong>A) HEMANGIOMA (Figs. 18 &amp; 19)</strong></p>
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>CAPILLARY HEMANGIOMA</th>
                                                <th>CAVERNOUS HEMANGIOMA</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>Sites: <br> 1- Skin, often since birth (birth mark). <br> 2- Mucus membranes of lip and tongue. <br> 3- Organs as brain &amp; kidney</td>
                                                <td>Sites: <br> 1- Skin, particularly of the face. <br> 2- Mucus membranes of lip &amp; tongue. <br> Macrochelia &amp; macroglossia may occur. <br> 3- Organs as liver, spleen &amp; muscles</td>
                                            </tr>
                                            <tr>
                                                <td>Gross: A deep red well defined patch.</td>
                                                <td>Gross: A purple well defined soft swelling.</td>
                                            </tr>
                                            <tr>
                                                <td>Microscopy: <br> Small vascular spaces lined by endothelium &amp; contain blood.</td>
                                                <td>Microscopy: <br> Wide vascular spaces lined by endothelium &amp; filled with blood.</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <p><strong>B) LYMPHANGIOMA</strong><br>
                            Definition: A benign hamartomatous (tumor-like) lesion of lymphatic vessels.<br>
                            Sites: 1- Skin particularly of head, neck and axilla. 2- Mucous membranes e.g. lip and tongue 3- Viscera as spleen, liver &amp; kidney<br>
                            Types, Gross &amp; Microscopic Features:<br>
                            Cavernous lymphangioma: This is the most common type:<br>
                            Grossly: A grayish pink swelling that may cause enlargement macrochelia (lip enlargement) or macroglossia (tongue enlargement).<br>
                            Microscopically: wide vascular channels, filled with pale eosinophilic lymph &amp;<br>
                            Cystic lymphangioma (cystic hygroma):<br>
                            Grossly: a huge congenital cystic swelling, composed of widely cystic lymphatic channels. It occurs at the side of the neck and may cause troubles delivery of the baby.<br>
                            Microscopically: like cavernous lymphangioma, but wider vascular lymphatic channels.<br>
                            Capillary lymphangioma: A small lesion composed of capillary spaces lined by endothelium &amp;filled with lymph</p>
                            
                            <p><strong>C) HEMANGIOENDOTHELIOMA:</strong> A rarer tumor composed of capillary spaces associated with prominent proliferation of endothelial cells. Some of these tumors are benign and others are of low grade malignancy<br>
                            <strong>D) OTHER BENIGN VASCULAR TUMORS:</strong> Glomangioma &amp; sclerosing hemangioma: See systemic pathology.</p>
                            
                            <div class="topics-grid">
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251212-7ca7f332.jpeg" alt="Fig. 18 Capillary hemangioma" class="figure-image">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 18 Capillary hemangioma</figcaption>
                                </figure>
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251212-3e29c68a.jpeg" alt="Fig. 19 Cavernous hemangioma" class="figure-image">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 19 Cavernous hemangioma</figcaption>
                                </figure>
                            </div>

                            <h4 id="benign-nerve-tumours">9) BENIGN TUMOURS OF NERVE SHEATH (see special)</h4>

                            <h3 id="malignant-mesenchymal">MALIGNANT MESENCHYMAL TUMORS (SARCOMAS)</h3>
                            <p>GENERAL CHARACTERS: See table page<br>
                            CLASSIFICATION:<br>
                            A) Differentiated Sarcomas:<br>
                            1- Liposarcoma 2- Fibrosarcoma 3- Rhabdomyosarcoma 4- Leiomyosarcoma 5- Angiosarcoma &amp; other malignant vascular tumors. 6- 0steosarcoma 7Chondrosarcoma<br>
                            B) Undifferentiated Sarcomas: These are sarcomas derived from different cell types (fibroblasts, osteoblasts, lipoblasts... etc.) but without differentiation that points to their cell of origin. These sarcomas are sometimes designated according to the predominant cell pattern e.g.<br>
                            a. Round cell sarcoma,<br>
                            b. Spindle cell sarcoma,<br>
                            c. Giant cell sarcoma</p>

                            <p><strong>1) LIPOSARCOMA</strong><br>
                            Origin: A malignant tumor of adipose tissue.<br>
                            Sites: Retroperitoneal, mesenteric, mediastinal, intermuscular, subcutaneous.<br>
                            Gross Picture: Large soft mass with foci of necrosis and hemorrhage.<br>
                            Microscopic Picture: In well differentiated liposarcoma, the malignant cells contain abundant intracytoplasmic fat. In undifferentiated (pleomorphic) liposarcoma, the malignant cells are extremely pleomorphic with very poor lipoblastic differentiation. Sometimes liposarcoma shows myxoid foci (myxoliposarcoma).<br>
                            Spread: Direct and blood spread. The well differentiated types have a much better prognosis than the other types.</p>

                            <p><strong>2) FIBROSARCOMA</strong><br>
                            Definition &amp; Origin: A malignant tumor of fibrous tissue. Sites: Subcutaneous, periosteal, intermuscular...<br>
                            Gross: A large grayish mass with areas of necrosis and hemorrhage.<br>
                            Microscopy: In well differentiated fibrosarcoma the malignant spindle cells are separated by abundant collagenous stroma. In less differentiated forms there is little collagen and more marked cellular anaplasia.<br>
                            Spread: Direct &amp; blood spread. Well differentiated fibrosarcoma has a better prognosis due to slow spread.</p>

                            <p><strong>3) RHABDOMYOSARCOMA</strong><br>
                            A malignant tumor of striated muscle. Three main types:<br>
                            1- Embryonal Rhabdomyosarcoma (sarcoma botryoides): occurs in children; mainly in urinary bladder, vagina and cervix. It consists of small spindle cells with dark nuclei in a myxoid matrix.<br>
                            2- Pleomorphic Rhabdomyosarcoma: occurs in adults in intermuscular septa and soft tissue. It consists of extremely pleomorphic cells, some of which may show cytoplasmic cross striations (strap cells).<br>
                            3- Alveolar Rhabdomyosarcoma: consists of malignant cells exhibiting alveolar arrangement.</p>

                            <p><strong>4) LEIOMYOSARCOMA</strong><br>
                            Definition &amp; Origin: A malignant tumor of smooth muscle.<br>
                            Sites: Most commonly uterus and GIT<br>
                            Gross: Large fleshy mass with areas of hemorrhage and necrosis.<br>
                            Microscopy: Malignant spindle cells with eosinophilic cytoplasm and large dark nuclei. Cytoplasmic actin can be detected by immunohistochemistry.<br>
                            Spread: Direct and blood spread (faster in less differentiated tumors)</p>

                            <p><strong>5) OTHERSARCOMAS</strong><br>
                            Malignant vascular tumors, osteosarcoma, chondrosarcoma... etc: See systemic pathology</p>

                            <p><strong>6) LYMPHOMA &amp; LEUKEMIA</strong><br>
                            Lymphomas are a group of primary malignant neoplasms of lymphoid tissue arising from B or T lymphocytes or rarely histiocytes.<br>
                            Leukemia is a malignant proliferation of one of the leukocyte forming tissue</p>
                        </div>
                    </section>
                    <!-- END: specific-mesenchymal -->

                    <!-- START: miscellaneous -->
                    <section id="miscellaneous" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">07</div>
                            <h2 class="section-title">MISCELLANEOUS BENIGN &amp; MALIGNANT TUMORS</h2>
                        </div>
                        
                        <div class="content-card">
                            <h3 id="melanocytic">1. PIGMENTED (MELANOCYTIC) TUMORS</h3>
                            <p>Definition: These are benign &amp; malignant tumors arising from melanocytes.<br>
                            Sites: 1. Skin 2. Mucous membranes &amp; mucocutaneous junctions (as conjunctiva, rectum, mouth &amp; vagina) 3. Eye as choriod and iris. 4. Leptomeninges.<br>
                            Classification:<br>
                            1- Pigmented nevus or mole: It may be:<br>
                            - Congenital nevus:<br>
                            - Acquired nevus including junctional, intradermal &amp; combined types.<br>
                            2- Malignant Melanoma.<br>
                            - It may grow vertically (nodular melanoma) .This type is more serious &amp; spreads rapidly<br>
                            - It may grow radially. This type is less dangerous than nodular melanoma</p>

                            <p><strong>A) BENIGN Lesion: (NEVUS or MOLE):</strong><br>
                            Definition: Benign tumour of the melanocytes. It is present in nearly every individual and usually dates since birth, so it is considered as a hamartomatous malformation.<br>
                            Sites: Skin is the most common site.<br>
                            Gross Picture: Small brown to black macules. Old nevi become depigmented<br>
                            Microscopic Picture: Acquired nevi develop along three phases:<br>
                            a) Junctional Nevus: Nests of nevus cells are seen, at the dermo-epidermal junction. These nevus cells are rounded melanocytes with ovoid nuclei and cytoplasmic melanin granules.<br>
                            b) Compound Nevus: This phase is characterized by appearance of intradermal groups of nevus cells along with the intraepidermal (junctional) nests.<br>
                            c) Intradermal Nevus: Over time, the intraepidermal nests disappear. Simultaneously, the dermal nevus cells become spindled and lose their melanin-7 depigmantation of old nevi.<br>
                            d) Other Types of nevi include<br>
                            Blue Nevus which is a congenital skin nevus appears blue in color. Microscopically it consists of deep intradermal pigmented elongated melanocytes. Malignant transformation is very rare.</p>
                            <p>Malignant Transformation of Nevi: It is relatively more common in patients with large number of acquired nevi. Malignancy is suspected when the size of nevus enlarges with ulceration, color changes &amp; regional lymph node enlargement</p>

                            <p><strong>B) MALIGNANT MELANOMA:</strong><br>
                            Definition &amp; Origin: A malignant tumor of melanocytes. It commonly arises de novo, but nodular melanoma may arise on top of pre-existing acquired or congenital nevi. Malignant transformation of a pre-existing nevus is suspected when the size enlarges with ulceration, color changes and regional lymph node enlargement.<br>
                            Age: Most common between 40-60years, but younger and older ages may be affected.<br>
                            Types: Clark classified malignant melanoma into:Two main patterns of growth: Radial and vertical.</p>
                            <p>A- Melanomas with Radial Pattern of Growth: Tumor grows laterally within the epidermis (in situ). Minimal dermal infiltration occurs later. Subtypes include:<br>
                            (1)Lentigo maligna: Arises from the sun-exposed skin of the elderly. The tumour appears as a slowly growing flat lesion of varying shades of brown colour. Microscopically the tumour is composed of dysplastic pleomorphic melanocytes spreading along the basal layer of epidermis and skin appendages. The prognosis is good but invasion and metastasis can occur, often after 10 years.<br>
                            (2)Superficial spreading melanoma: Occurs on any area of the skin but is most common on the back of men and lower legs in women. The tumour appears as a flat or slightly raised brown to black lesion with irregular border. Microscopically there is proliferation of atypical melanocytes at the dermoepidermal junction together with invasion of the epidermis by malignant cells arranged singly or in small groups. Sooner or later there is vertical growth phase, the dermis is invaded and a nodule develops.<br>
                            (3)Acrallentiginous melanoma: Affects the palms and soles. The lesion appears as a pigmented macule. Histologically it resembles lentigo maligna. Soon, however an invasive often spindlecelled tumour arises and the prognosis is poor.</p>
                            <p>B- Melanoma with Vertical Pattern of Growth (Nodular Melanoma) A malignant tumor of melanocytes. It commonly arises de novo, but may arise on top of pre-existing acquired or congenital nevi. Most common above age of 40 y . The tumour forms a rapidly growing dark brown nodular ulcerating mass. Microscopically the malignant cells invade the epidermis and dermis (vertical growth). The depth of invasion in the dermis and subcutaneous fat is an important prognostic factor. The tumour cells show one of two patterns:<br>
                            a) Masses of round or polyhydral epithelioid-like cells separated by fine vascular stroma.<br>
                            b) Spindle shaped malignant cells scattered or in bundles.<br>
                            Melanin pigment is found both intracellular and extracellular. Few tumours are nonpigmented and are known as amelanotic melanomas.<br>
                            Prognosis: It depends on the depth of invasion by measuring the vertical extent of tumor below the stratum granulosum (Clark's level). However prognosis is generally poor due to rapid spread of tumor by all routes.</p>
                            <p>Spread: a) Local spread b) lymphatic spread to regional lymph nodes c) Blood spread.</p>

                            <h3 id="teratoma">2) TERATOMA</h3>
                            <p>Definition, origin &amp; sites: Teratoma is a composite tumor containing structures derived from ectoderm, mesoderm &amp; endoderm. It arises from primitive germ cells or totipotent cells that may exist in post-natal life in some places as ovary, testis, sacrococygeal region &amp; mediastinum. The structure of teratoma is foreign to the site from which it arises</p>
                            <p>Types:<br>
                            A- MATURE TERATOMA (Benign Teratoma):<br>
                            These tumors consist of a haphazard mixture of mature ectodermal structures such as skin, neuroglial cells &amp; teeth, mature endodermal structures such as thyroid tissue &amp; other types of glandular epithelium &amp; mature mesodermal structures such as cartilage, bone, adipose tissue, fibrous tissue, muscle ... etc. It maybe cystic &amp; consist predominantly of skin &amp; hairs (dermoid cyst)<br>
                            Malignant transformation occurs in $1 \%$ of mature teratomas (any type of malignancy, but squamous cell carcinoma is the most common).<br>
                            Microscopically: These mixed mature structures can be easily recognized<br>
                            Grossly, mature teratomas are of two types:<br>
                            a) Cystic Teratoma (DERMOID CYST) (Fig 20): Commonest in ovary. Usually large.<br>
                            It consists of: - A dermoid ridge which IS a solid part covered by skin.<br>
                            &gt; The rest of the tumor is cystic and contains sebaceous material, tufts of hair, teeth and other structures.<br>
                            b) Solid Teratoma: Less common</p>
                            <p>B- IMMATURE TERATOMA (Malignant Teratoma):<br>
                            - It consists of a varied amount of immature tissues (immature cartilage, neuroepithelium, glands... etc).<br>
                            - The degree of malignancy and spread is proportionate to the degree of immaturity.<br>
                            - According to the proportion of immature to mature structures,<br>
                            - This group is subtyped as grade I, grade II &amp; grade III</p>
                            <p>C- MONODERMAL TERATOMAS (Specialized Teratomas):<br>
                            These are teratomas that differentiate along the line of a single abnormal tissue.<br>
                            Examples:<br>
                            a) Struma ovarii: A benign ovarian teratoma composed of thyroid tissue.<br>
                            b) Ovarian or testicular choriocarcinoma: A malignant placental epithelial tumor.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-861c0c38.jpeg" alt="Fig. 20 Dermoid cyst" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 20 Dermoid cyst</figcaption>
                            </figure>

                            <h3 id="embryonic-tumors">3) EMBRYONIC TUMORS (Fig.21)</h3>
                            <p>Definition, origin and age: Malignant tumors derived from embryonic cell remnants ( multipotential cells) (Ectoderm, endoderm or mesoderm) in infants and young children<br>
                            Structure: They consist of primitive embryonic (undifferentiated) malignant small round cells. However some of these cells may partially differentiate into mature tissues of the same class from which these embryonic cells are derived (e.g. mesodermal tissues as smooth muscle &amp; cartilage in embryonic tumors derived from mesodermal cells)<br>
                            Examples:<br>
                            1- Neuroblastoma of adrenal medulla &amp; sympathetic ganglia.<br>
                            2- Retinoblastoma of eye.<br>
                            3- Nephroblastoma of kidney.<br>
                            4- Hepatoblastoma of liver.<br>
                            5- Medulloblastoma of brain.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-ed2bbdd0.jpeg" alt="Fig. 21 Embryoma kidney" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 21 Embryoma kidney</figcaption>
                            </figure>
                        </div>
                    </section>
                    <!-- END: miscellaneous -->

                    <!-- START: management -->
                    <section id="management" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">08</div>
                            <h2 class="section-title">DIAGNOSIS, PROGNOSIS &amp; MANAGEMENT</h2>
                        </div>
                        
                        <div class="content-card">
                            <h3 id="lab-diagnosis">LABORATORY DIAGNOSIS OF NEOPLASIA</h3>
                            <ol class="enhanced-list">
                                <li class="list-item">Biopsy specimens: Stained paraffin sections or frozen sections can easily prepared and microscopicallyexamined.</li>
                                <li class="list-item">Fine-needle aspiration Using a needle, aspiration of tumor cells is obtained, stained and examined microscopically</li>
                                <li class="list-item">Cytological Examination Fluids such as ascites, pleural effusions, CSF and urine may contain related tumors. Using a centrifuge, any floating cells detached malignant cells form a sediment, from which films can be prepared on glass slides, stained andexamined.</li>
                                <li class="list-item">DNA Flow Cytometry: Measurement of the DNA content of tumor cells by flow cytometry shows abnormal DNA content.</li>
                                <li class="list-item">Tumor Markers (Fig. 22):
                                    <p>These are tumor-derived or associated molecules. They may be secreted in the blood (serum tumor markers) and can be detected within the tumor cells (tissue tumor markers).</p>
                                    <p>a) Serum Tumor markers detected within the blood:</p>
                                    <ul>
                                        <li>Carcinoembryonic antigen (CEA) in cases of cancer colon, stomach, pancreas and breast.</li>
                                        <li>Alphafetoprotein (AFP) in cases of hepatic cancer and germ cell tumors.</li>
                                        <li>Prostatic specific antigen (PSA) and prostatic acid phosphatase in case of cancer prostate.</li>
                                    </ul>
                                    <p>b) Tissue Markers localized within tumor cellsThese can be detected by a special technique called IMMUNOHISTOCHEMISTRY. Tissue tumor markers may be detected on the cell membrane, cytoplasm or nuclei. Assessment of tumor markers can be of diagnostic value (particularly in undifferentiated malignant tumors). Some Markers or of prognostic value (as Her 2 which denotes \ higher tendency for metastases). Few examples of diagnostic tumor markers are given:</p>
                                    <ul>
                                        <li>Cytokeratin and EMA (epithelial membrane antigen) in epithelial tumors Icarcinoma</li>
                                        <li>Vimentin in mesenchymal tumors Isarcoma.</li>
                                        <li>Common leukocyte antigen for lymphomas.</li>
                                        <li>S-100 protein in neural tumors, melanoma &amp; cartilaginous tumors</li>
                                        <li>HMB 45 in melanoma.</li>
                                        <li>Desmin in muscle tumors.</li>
                                    </ul>
                                </li>
                            </ol>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251212-b9dbcac6.jpeg" alt="Fig. 22 CEA positive brown tumour cells" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 22 CEA positive brown tumour cells</figcaption>
                            </figure>

                            <h3 id="prognosis-factors">FACTORS INFLUENCING THE PROGNOSIS OF MALIGNANT TUMORS</h3>
                            <ol class="enhanced-list">
                                <li class="list-item">Tumor Type: e.g. malignant melanoma &amp; most sarcomas have poorer prognosis than carcinomas.</li>
                                <li class="list-item">Tumor Site: e.g. superficial tumors as those arising from skin are diagnosed earlier and treated easier than deeply seated tumors and brain tumors.</li>
                                <li class="list-item">Differentiation: Well differentiated tumors grow slower than less differentiated ones.</li>
                                <li class="list-item">Tumor Stage: There are different methods for tumor staging, one of the popular methods is the TNM system:</li>
                                <li class="list-item">Immune Host Responses: The tumor cells have antigens capable of evoking an immune response.</li>
                                <li class="list-item">Efficiency of treatment</li>
                                <li class="list-item">Age: Tumors of infants and children are generally regarded of poorer prognosis (with exceptions).</li>
                                <li class="list-item">Tumor Hormone Receptors: The growth of some tumors depends partly on hormone stimulation. The cells of such tumors have hormone receptors. Examples include oestrogen receptor positive breast carcinoma and androgen receptor positive prostatic carcinoma. Depriving these tumors from hormone stimulation helps in controlling their growth. Example anti-oestrogen therapy ($\pm$ oophorectomy) for breast cancer and antiandrogen therapy ($\pm$ orchidectomy) for prostatic cancer. Thus, a hormone receptor positive Tumor is better than a hormone receptor negative Tumor.</li>
                                <li class="list-item">Growth Fraction (GF): This is the proportion of cells within the neoplasm entering the cell cycle (i.e. out of GO phase). The importance of GF is that most antineoplastic drugs act on dividing cells; thus tumors with high GF are the most susceptible to anticancer agents &amp; are also the most rapidly growing if left untreated.</li>
                            </ol>

                            <h3 id="management">MANAGEMENT OF BENIGN &amp; MALIGNANT TUMOURS</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">SURGERY: Benign tumours - removal of tumour only (Iumpectomy) Malignant tumours- removal of tumour, the tissues around it sometimes the whore organ and removal of draining lymph nodes (radical surgery)</li>
                                <li class="list-item">CHEMOTHERAPY: interferes with metabolism of proliferating cells a) Protein synthesis b) DNA block</li>
                                <li class="list-item">RADIOTHERAPY: causes DNA breaks
                                    <ul>
                                        <li>&gt; Direct damage of DNA molecule</li>
                                        <li>&gt; Breaks in cell &amp; organelle membranes</li>
                                        <li>&gt; Inhibition of important proteins &amp; enzymes</li>
                                        <li>&gt; Toxic damage by ionization of Intra cellular water</li>
                                    </ul>
                                </li>
                                <li class="list-item">HORMONAL THERAPY: a) Drugs b) Surgical ablation (removal of ovaries or castration)</li>
                                <li class="list-item">IMMUNOTHERAPY: Non specific vaccines BeG boosts immunity in general; Interferon &amp; interleukin 2 therapy</li>
                                <li class="list-item">GENE THERAPY</li>
                                <li class="list-item">VIROTHERAPY ( under trial in animals) NEW</li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: management -->
                    
                    <!-- Key Points Section -->
                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Priorities</h3>
                            </div>
                            <p style="color: white; margin-bottom: 1rem;">Category A 80% of exam Category B 15% of exam Category C 5% of exam</p>
                            <div class="table-container">
                                <table class="content-table" style="color: white;">
                                    <thead>
                                        <tr>
                                            <th style="color: white; border-color: rgba(255,255,255,0.2);">Topic</th>
                                            <th style="color: white; border-color: rgba(255,255,255,0.2);">Subtopic</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td style="border-color: rgba(255,255,255,0.1);">Dist of growth &amp; neoplasia</td>
                                            <td style="border-color: rgba(255,255,255,0.1);">ALL</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </aside>

                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="topic-08-neoplasia.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Neoplasia Pt.1</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="topic-09-cytology-environmental.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Cytology & Env.</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>